Nusayba A Bagegni Selected Research

vorolanib

1/2022

Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nusayba A Bagegni Research Topics

Disease

3	Neoplasms (Cancer) 06/2022 - 01/2019
2	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2021
2	Triple Negative Breast Neoplasms 01/2022 - 01/2019
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 06/2022
1	Diarrhea 06/2022
1	Exanthema (Rash) 01/2022
1	Pathologic Complete Response 01/2022
1	Fatigue 01/2022
1	Hemorrhage 01/2022
1	Leukopenia 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Radiation induced brachial plexopathy 01/2021
1	Aortic Aneurysm (Aneurysm, Aortic) 12/2007
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2007
1	Rheumatoid Arthritis 12/2007
1	Atherosclerosis 12/2007
1	Emphysema 12/2007

Drug/Important Bio-Agent (IBA)

2	pembrolizumabIBA 01/2022 - 01/2022
1	AntidiarrhealsIBA 06/2022
1	ErbB Receptors (EGF Receptor)IBA 06/2022
1	Colestipol (Colestid)FDA LinkGeneric 06/2022
1	Loperamide (Imodium)FDA LinkGeneric 06/2022
1	neratinibIBA 06/2022
1	cyclopropapyrroloindoleIBA 01/2022
1	NivolumabIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	vorolanibIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Biological ProductsIBA 01/2019
1	Matrix Metalloproteinase 12IBA 12/2007

Therapy/Procedure

2	Neoadjuvant Therapy 01/2022 - 01/2019
1	Therapeutics 06/2022
1	Radiotherapy 01/2021
1	Adjuvant Chemotherapy 01/2019
1	Drug Therapy (Chemotherapy) 01/2019